Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 2
1975 1
1976 2
1977 1
1978 2
1979 2
1980 3
1981 3
1982 1
1983 1
1984 2
1986 3
1987 3
1988 4
1989 5
1990 2
1994 1
1995 3
1996 1
1997 2
1998 2
1999 1
2000 1
2001 2
2002 6
2003 4
2004 6
2005 2
2006 1
2007 1
2008 1
2009 1
2010 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

72 results
Results by year
Filters applied: . Clear all
Page 1
Diversity of the osteoblastic phenotype.
Rodan GA, Heath JK, Yoon K, Noda M, Rodan SB. Rodan GA, et al. Among authors: rodan sb. Ciba Found Symp. 1988;136:78-91. doi: 10.1002/9780470513637.ch6. Ciba Found Symp. 1988. PMID: 3068018 Review.
Involvement of alpha(v)beta3 integrins in osteoclast function.
Nakamura I, Duong LT, Rodan SB, Rodan GA. Nakamura I, et al. Among authors: rodan sb. J Bone Miner Metab. 2007;25(6):337-44. doi: 10.1007/s00774-007-0773-9. Epub 2007 Oct 25. J Bone Miner Metab. 2007. PMID: 17968485 Review.
Integrin function in osteoclasts.
Rodan SB, Rodan GA. Rodan SB, et al. J Endocrinol. 1997 Sep;154 Suppl:S47-56. J Endocrinol. 1997. PMID: 9379137 Review.
The discovery of MK-0674, an orally bioavailable cathepsin K inhibitor.
Isabel E, Bateman KP, Chauret N, Cromlish W, Desmarais S, Duong LT, Falgueyret JP, Gauthier JY, Lamontagne S, Lau CK, Léger S, LeRiche T, Lévesque JF, Li CS, Massé F, McKay DJ, Mellon C, Nicoll-Griffith DA, Oballa RM, Percival MD, Riendeau D, Robichaud J, Rodan GA, Rodan SB, Seto C, Thérien M, Truong VL, Wesolowski G, Young RN, Zamboni R, Black WC. Isabel E, et al. Among authors: rodan sb. Bioorg Med Chem Lett. 2010 Feb 1;20(3):887-92. doi: 10.1016/j.bmcl.2009.12.083. Epub 2009 Dec 28. Bioorg Med Chem Lett. 2010. PMID: 20061146
Identification of a potent and selective non-basic cathepsin K inhibitor.
Li CS, Deschenes D, Desmarais S, Falgueyret JP, Gauthier JY, Kimmel DB, Léger S, Massé F, McGrath ME, McKay DJ, Percival MD, Riendeau D, Rodan SB, Thérien M, Truong VL, Wesolowski G, Zamboni R, Black WC. Li CS, et al. Among authors: rodan sb. Bioorg Med Chem Lett. 2006 Apr 1;16(7):1985-9. doi: 10.1016/j.bmcl.2005.12.071. Epub 2006 Jan 18. Bioorg Med Chem Lett. 2006. PMID: 16413777
The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K.
Gauthier JY, Chauret N, Cromlish W, Desmarais S, Duong LT, Falgueyret JP, Kimmel DB, Lamontagne S, Léger S, LeRiche T, Li CS, Massé F, McKay DJ, Nicoll-Griffith DA, Oballa RM, Palmer JT, Percival MD, Riendeau D, Robichaud J, Rodan GA, Rodan SB, Seto C, Thérien M, Truong VL, Venuti MC, Wesolowski G, Young RN, Zamboni R, Black WC. Gauthier JY, et al. Among authors: rodan sb. Bioorg Med Chem Lett. 2008 Feb 1;18(3):923-8. doi: 10.1016/j.bmcl.2007.12.047. Epub 2008 Jan 15. Bioorg Med Chem Lett. 2008. PMID: 18226527
The role of prostaglandins in bone formation.
Harada SI, Balena R, Rodan GA, Rodan SB. Harada SI, et al. Among authors: rodan sb. Connect Tissue Res. 1995;31(4):279-82. doi: 10.3109/03008209509010823. Connect Tissue Res. 1995. PMID: 15612368
Design and synthesis of tri-ring P3 benzamide-containing aminonitriles as potent, selective, orally effective inhibitors of cathepsin K.
Palmer JT, Bryant C, Wang DX, Davis DE, Setti EL, Rydzewski RM, Venkatraman S, Tian ZQ, Burrill LC, Mendonca RV, Springman E, McCarter J, Chung T, Cheung H, Janc JW, McGrath M, Somoza JR, Enriquez P, Yu ZW, Strickley RM, Liu L, Venuti MC, Percival MD, Falgueyret JP, Prasit P, Oballa R, Riendeau D, Young RN, Wesolowski G, Rodan SB, Johnson C, Kimmel DB, Rodan G. Palmer JT, et al. Among authors: rodan sb. J Med Chem. 2005 Dec 1;48(24):7520-34. doi: 10.1021/jm058198r. J Med Chem. 2005. PMID: 16302794
72 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page